Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

Clinical trial NCT05671835 · COMPLETED

Trial details

NCT number: NCT05671835
Sponsor: Tvardi Therapeutics, Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-05-15
Primary completion: 2025-08-14
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.